Home › Dermatitis › California › Los Angeles
Dermatitis clinical trials in Los Angeles, CA
4 studies for Dermatitis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
RecruitingPhase 3
- California Allergy & Asthma Medical Group, Los Angeles
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 23, Los Angeles
Dermatitis trials in other cities
- Birmingham, AL6 studies
- Miami, FL5 studies
- Little Rock, AR4 studies
- Huntington Beach, CA4 studies
- San Antonio, TX3 studies
- Santa Clarita, CA3 studies
- Fargo, ND3 studies
- Tampa, FL3 studies
- Dallas, TX3 studies
- Lewisville, TX3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer92 studies
- Breast Cancer73 studies
- Cancer (all types)73 studies
- Prostate Cancer64 studies
- Colorectal Cancer61 studies
- Metastatic Cancer57 studies
- Ovarian Cancer53 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma43 studies
- Pancreatic Cancer36 studies
- Endometrial Cancer35 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.